HCPCS Code Descriptor:
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
Yupelri is a Respiratory drug manufactured by Mylan and administered via the Inhalation route of administration. The J Code: J7677 is aligned to the drug Yupelri.
Access Pricing and More By Registering
HCPCS Added Date:
HCPCS Effective Date:
HCPCS Short Description:
Revefenacin inh non-com 1mcg
Billing and Coding Guide: